Cargando…
Dihydromyricetin Ameliorates Cardiac Ischemia/Reperfusion Injury through Sirt3 Activation
During myocardial infarction, quickly opening the occluded coronary artery is a major method to save the ischemic myocardium. However, it also induces reperfusion injury, resulting in a poor prognosis. Alleviating the reperfusion injury improves the prognosis of the patients. Dihydromyricetin (DHM),...
Autores principales: | Wei, Liping, Sun, Xuseng, Qi, Xin, Zhang, Yufan, Li, Yuanyang, Xu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500683/ https://www.ncbi.nlm.nih.gov/pubmed/31139646 http://dx.doi.org/10.1155/2019/6803943 |
Ejemplares similares
-
Ubiquitin-proteasomes are the dominant mediators of the regulatory effect of microRNA-1 on cardiac remodeling after myocardial infarction
por: Wei, Liping, et al.
Publicado: (2019) -
Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway
por: He, Hong, et al.
Publicado: (2023) -
P‑hydroxybenzyl alcohol ameliorates neuronal cerebral ischemia‑reperfusion injury by activating mitochondrial autophagy through SIRT1
por: Yu, Xinglin, et al.
Publicado: (2023) -
Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
por: Cheng, Quan-Cheng, et al.
Publicado: (2020) -
Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis
por: Xie, Jiangbo, et al.
Publicado: (2022)